UPL Limited’s $4.2 Billion Acquisition of Arysta LifeScience Inc.

Jones Day, J. Sagar Associates, Greenberg Traurig, Cleary Gottlieb Steen & Hamilton and González Calvillo advised on the deal.

UPL Corporation signed a definitive agreement with Platform Specialty Products Corporation to acquire Arysta LifeScience Inc. and its subsidiaries for approximately $4.2 billion in cash consideration.

Abu Dhabi Investment Authority (“ADIA”), and leading global alternative asset firm TPG, have partnered with UPL Corporation Limited to support UPL Corp’s planned acquisition of Arysta LifeScience Inc.

Arysta LifeScience is a global provider of innovative crop protection solutions, including BioSolutions and Seed Treatment.

Following the acquisition, UPL will be one of the world’s largest global crop protection companies, with differentiated product portfolio, the company said in a filing to BSE.

UPL Limited, together with its subsidiaries, manufactures and markets agrochemicals, industrial chemicals, chemical intermediates, and specialty chemicals in India, Europe, North America, Latin America, and internationally. The company, led by Ashutosh Kumar Awasthi is based in Mumbai.

Jones Day advised UPL Limited with a team led by Karthik Kumar (Picture), Dennis Barsky and Sushma Jobanputra.

Cleary Gottlieb Steen & Hamilton advised Abu Dhabi Investment Authority – ADIA and TPG Capital on the transaction

In Mexico, González Calvillo advised Abu Dhabi Investment Authority – ADIA and TPG Capital with Cristina Massa Sánchez and Raúl Paniahua.

Involved fees earner: Cristina Massa – Gonzalez Calvillo Abogados; Raúl Paniahua Reyes – Gonzalez Calvillo Abogados; Dennis Barsky – Jones Day; Sushma Jobanputra – Jones Day; Karthik Kumar – Jones Day;

Law Firms: Gonzalez Calvillo Abogados; Jones Day;

Clients: Abu Dhabi Investment Authority (ADIA); TPG Capital; UPL Limited;

Author: Michael Patrini